Minerva Neurosciences, Inc. (NERV)
2.32
+0.08
(+3.57%)
USD |
NASDAQ |
Oct 30, 16:00
2.30
-0.02
(-0.86%)
After-Hours: 20:00
Minerva Neurosciences EPS Diluted (Quarterly) : -0.1379 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1379 |
| March 31, 2026 | -2.857 |
| December 31, 2025 | -25.51 |
| September 30, 2025 | -0.3625 |
| June 30, 2025 | -0.4305 |
| March 31, 2025 | -0.4958 |
| December 31, 2024 | -0.5644 |
| September 30, 2024 | 2.974 |
| June 30, 2024 | -1.088 |
| March 31, 2024 | -1.132 |
| December 31, 2023 | -1.192 |
| September 30, 2023 | -1.033 |
| June 30, 2023 | -1.124 |
| March 31, 2023 | -1.305 |
| December 31, 2022 | -1.260 |
| September 30, 2022 | -1.292 |
| June 30, 2022 | -1.632 |
| March 31, 2022 | -1.828 |
| December 31, 2021 | -3.990 |
| September 30, 2021 | -1.724 |
| June 30, 2021 | -1.983 |
| March 31, 2021 | -1.649 |
| December 31, 2020 | -1.372 |
| September 30, 2020 | -1.548 |
| June 30, 2020 | 5.865 |
| Date | Value |
|---|---|
| March 31, 2020 | -2.481 |
| December 31, 2019 | -6.131 |
| September 30, 2019 | -2.862 |
| June 30, 2019 | -2.558 |
| March 31, 2019 | -3.249 |
| December 31, 2018 | -2.716 |
| September 30, 2018 | -2.480 |
| June 30, 2018 | -2.587 |
| March 31, 2018 | -2.564 |
| December 31, 2017 | 0.0334 |
| September 30, 2017 | -2.24 |
| June 30, 2017 | -2.16 |
| March 31, 2017 | -2.40 |
| December 31, 2016 | -2.16 |
| September 30, 2016 | -1.92 |
| June 30, 2016 | -1.44 |
| March 31, 2016 | -2.32 |
| December 31, 2015 | -2.72 |
| September 30, 2015 | -1.92 |
| June 30, 2015 | -2.16 |
| March 31, 2015 | -2.48 |
| December 31, 2014 | -3.20 |
| September 30, 2014 | -12.24 |
| June 30, 2014 | -20.40 |
| March 31, 2014 | -0.0013 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Heron Therapeutics, Inc. | -0.0288 |
| Tonix Pharmaceuticals Holding Corp. | -2.438 |
| Karyopharm Therapeutics, Inc. | -2.316 |
| Corbus Pharmaceuticals Holdings, Inc. | -1.805 |
| Ocugen, Inc. | -0.0734 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 17.47M |
| Total Expenses (Quarterly) | -17.47M |
| Enterprise Value | 105.94M |
| Earnings Yield | -1.24K% |
| Normalized Earnings Yield | -422.06 |